FAT1 and metabolic dysfunction-associated steatotic liver disease: Fat-1, an enzyme, is in charge of converting endogenous omega-6 polyunsaturated fatty acids (PUFAs) into omega-3 PUFAs and alleviates MASLD by enhancing PPARα-mediated fatty acid oxidation [76].